p53 and pathways of apoptosis
p53 and pathways of apoptosis
批准号:
8082770
负责人:
DONNA L GEORGE
金额:
$29.03万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-07 至 2013-05-31
关键词:
AddressApoptosisBackBindingCancer BiologyCell Cycle ArrestCell DeathCell Death InductionCell Death Signaling ProcessCell SurvivalCellsCellular StressCessation of lifeDataDevelopmentDiseaseEquilibriumGenesGoalsGrowthHepaticHepatocyteInduction of ApoptosisInjuryInsulin-Like Growth-Factor Binding Protein 1InvestigationLinkLiverMalignant NeoplasmsMalignant neoplasm of liverMeasuresMediatingMediator of activation proteinMitochondriaModelingMusNeoplastic liverNuclearOutcomePathway interactionsPhysiologicalPlayProtein p53ProteinsRegulationResearchResearch Project GrantsRoleSignal PathwaySignal TransductionStressTestingTherapeuticTissuesTumor SuppressionWorkbasebiological adaptation to stressdesignfeedinginsightmouse modelresponsesenescencetranscription factortumorigenesis
中文摘要
描述(由申请人提供):p53蛋白在肿瘤抑制中起关键作用,代表细胞对内在和外在应激信号反应的关键介质。作为一种核转录因子,p53具有激活或抑制大量基因表达的能力。越来越多的证据表明,p53还具有非转录功能,在线粒体中直接作用于促进细胞凋亡。应激介导的p53活化的结果通常是生长停滞或细胞死亡(凋亡)。如何作出这种“决定”在该领域仍然是一个未解决的问题,并且一般被描述为由“细胞环境”或由促存活因子或促凋亡因子的平衡决定。因此,定义和表征控制这一重要决定并介导p53多种活动的关键细胞决定因素的目标在癌症生物学中至关重要。该研究项目的重点是我们最近发现的肝脏存活因子,胰岛素样生长因子结合蛋白1(IGFBP 1)和p53蛋白之间的功能联系。虽然在许多组织中,p53激活导致细胞死亡,但我们的数据表明,肝细胞中的p53也具有细胞保护作用。因此,主要目标将是研究p53/IGFBP 1反馈回路是否是介导正常和肿瘤性肝细胞的应激反应结果的关键途径的一部分。这些研究集中在与p53在应激反应中的作用方式相关的重要问题上,包括:线粒体p53对凋亡的贡献,p53功能的关键调节剂的鉴定和表征,以及决定应激激活的p53是否会促进生存或凋亡的因素。同时,他们解决了促生存/促再生蛋白IGFBP 1的细胞内作用机制。所获得的信息将提供一个必要的框架,需要更深入地了解影响正常和肿瘤肝细胞中细胞死亡信号传导机制的决定,这是合理设计治疗癌症和易患癌症的肝脏疾病的有效治疗策略所需的理解。
英文摘要
DESCRIPTION (provided by applicant): The p53 protein plays a critical role in tumor suppression, and represents a pivotal mediator of cellular responses to both intrinsic and extrinsic stress signals. As a nuclear transcription factor, p53 has the ability to activate, or repress, the expression a large number of genes. Accumulating evidence suggests that p53 also has a non-transcriptional function with a direct role at mitochondria in promoting apoptosis. The outcome of stress-mediated p53 activation generally is growth arrest or cell death (apoptosis). How this "decision" is made remains an unresolved question in the field, and is described in general terms as being determined by "cell context" or by the balance of prosurvival or proapoptotic factors. Thus, the goal of defining and characterizing key cellular determinants that control this important decision and mediate the diverse activities of p53 is of central importance in cancer biology. The focus of this research project centers on our very recent discovery of a functional link between a liver survival factor, insulin-like growth factor binding protein 1 (IGFBP1), and the p53 protein. While in many tissues, p53 activation leads to cell death, our data suggest that p53 in liver cells also has a cytoprotective role. Thus, a primary goal will be to investigate whether a p53/IGFBP1 feed-back circuit is part of a crucial pathway mediating the stress- response outcome of normal and neoplastic liver cells. These investigations center on important issues related to the ways p53 acts in response to stress, including: the contribution of mitochondrial p53 to apoptosis, the identification and characterization of critical modulators of p53 function, and the factors that determine whether stress-activated p53 will promote survival or apoptosis. In conjunction, they address the intracellular mechanism of action of the prosurvival/proregeneration protein, IGFBP1. The information obtained will provide an essential framework needed for development of greater insight into decisions that influence cell death signaling mechanisms in normal and neoplastic liver cells, an understanding that is needed for the rational design of effective therapeutic strategies in treating cancers and hepatic diseases that predispose to cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
p53 and pathways of apoptosis
-
批准号:7480388
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:DONNA L GEORGE
-
依托单位:
p53 and pathways of apoptosis
-
批准号:7264316
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:DONNA L GEORGE
-
依托单位:
p53 and pathways of apoptosis
-
批准号:7631227
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:DONNA L GEORGE
-
依托单位:
p53 and pathways of apoptosis
-
批准号:7860452
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:DONNA L GEORGE
-
依托单位:
MODULATORS AND EFFECTORS OF MDM2 AND P53
-
批准号:6633893
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2001
-
负责人:DONNA L GEORGE
-
依托单位:
MODULATORS AND EFFECTORS OF MDM2 AND P53
-
批准号:6860097
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2001
-
负责人:DONNA L GEORGE
-
依托单位:
MODULATORS AND EFFECTORS OF MDM2 AND P53
-
批准号:6229388
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2001
-
负责人:DONNA L GEORGE
-
依托单位:
MODULATORS AND EFFECTORS OF MDM2 AND P53
-
批准号:6514829
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2001
-
负责人:DONNA L GEORGE
-
依托单位:
MODULATORS AND EFFECTORS OF MDM2 AND P53
-
批准号:6711083
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2001
-
负责人:DONNA L GEORGE
-
依托单位:
MDM2 AND P53 IN TUMOR CELLS
-
批准号:2110198
-
项目类别:
-
资助金额:$25.61万
-
财政年份:1996
-
负责人:DONNA L GEORGE
-
依托单位:
MDM2 AND P53 IN TUMOR CELLS
-
批准号:2871850
-
项目类别:
-
资助金额:$28.07万
-
财政年份:1996
-
负责人:DONNA L GEORGE
-
依托单位:
MDM2 AND P53 IN TUMOR CELLS
-
批准号:2654166
-
项目类别:
-
资助金额:$27.13万
-
财政年份:1996
-
负责人:DONNA L GEORGE
-
依托单位:
MDM2 AND P53 IN TUMOR CELLS
-
批准号:6150194
-
项目类别:
-
资助金额:$29.2万
-
财政年份:1996
-
负责人:DONNA L GEORGE
-
依托单位:
MDM2 AND P53 IN TUMOR CELLS
-
批准号:2330919
-
项目类别:
-
资助金额:$26.1万
-
财政年份:1996
-
负责人:DONNA L GEORGE
-
依托单位:
ETIOLOGY AND PATHOBIOLOGY OF MENINGIOMAS
-
批准号:3416954
-
项目类别:
-
资助金额:$25.14万
-
财政年份:1991
-
负责人:DONNA L GEORGE
-
依托单位:
ETIOLOGY AND PATHOBIOLOGY OF MENINGIOMAS
-
批准号:3416955
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1991
-
负责人:DONNA L GEORGE
-
依托单位:
ETIOLOGY AND PATHOBIOLOGY OF MENINGIOMAS
-
批准号:3416956
-
项目类别:
-
资助金额:$26.77万
-
财政年份:1991
-
负责人:DONNA L GEORGE
-
依托单位:
ETIOLOGY AND PATHOBIOLOGY OF MENINGIOMAS
-
批准号:2268119
-
项目类别:
-
资助金额:$27.91万
-
财政年份:1991
-
负责人:DONNA L GEORGE
-
依托单位:
ROLE OF DOUBLE MINUTES AND HSR MARKERS IN TUMOR CELLS
-
批准号:3172171
-
项目类别:
-
资助金额:$10.02万
-
财政年份:1982
-
负责人:DONNA L GEORGE
-
依托单位:
ROLE OF DOUBLE MINUTES AND HSR MARKERS IN TUMOR CELLS
-
批准号:3172170
-
项目类别:
-
资助金额:$11.93万
-
财政年份:1982
-
负责人:DONNA L GEORGE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: